Dr. Wagner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3699 Epworth Rd
Newburgh, IN 47630Phone+1 812-471-1200Fax+1 812-475-6700
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2004 - 2007
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2001 - 2004
Ross University School of MedicineClass of 2001
Certifications & Licensure
OH State Medical License Current
IN State Medical License 2008 - 2025
KY State Medical License 2004 - 2015
NC State Medical License 2007 - 2009
MI State Medical License 2001 - 2004
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
- Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2012 Aug 20
Publications & Presentations
PubMed
- 186 citationsAssociation of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A P...Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim
JAMA Oncology. 2023-01-01 - 26 citationsDetection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer.Sakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill
Journal for Immunotherapy of Cancer. 2022-06-01 - 24 citationsA randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaSara Kochanny, Francis P. Worden, Douglas Adkins, D. Lim, Julie E. Bauman
Cancer. 2020-05-15
Press Mentions
Oncologist Brings Specialty to Columbus RegionalOctober 2nd, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
